21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Stephan G, Huang L, Tang Y, Vilotti S, Fabbretti E, Yu Y, Nörenberg W, Franke H, Gölöncsér F, Sperlágh B, Dopychai A, Hausmann R, Schmalzing G, Rubini P, Illes P. Author Correction: The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel. Nature Communications. 9: 3351. PMID 30120221 DOI: 10.1038/s41467-018-05621-7  0.32
2018 Kaluza L, Meents JE, Hampl M, Rösseler C, Hautvast PAI, Detro-Dassen S, Hausmann R, Schmalzing G, Lampert A. Loss-of-function of Nav1.8/D1639N linked to human pain can be rescued by lidocaine. Pflugers Archiv : European Journal of Physiology. PMID 30099632 DOI: 10.1007/s00424-018-2189-x  0.32
2018 Stephan G, Huang L, Tang Y, Vilotti S, Fabbretti E, Yu Y, Nörenberg W, Franke H, Göröncsér F, Sperlágh B, Dopychai A, Hausmann R, Schmalzing G, Rubini P, Illes P. The ASIC3/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel. Nature Communications. 9: 1354. PMID 29636447 DOI: 10.1038/s41467-018-03728-5  0.32
2016 Xie J, Liu S, Wu B, Li G, Rao S, Zou L, Yi Z, Zhang C, Jia T, Zhao S, Schmalzing G, Hausmann R, Nie H, Li G, Liang S. The protective effect of resveratrol in the transmission of neuropathic pain mediated by the P2X7 receptor in the dorsal root ganglia. Neurochemistry International. PMID 28027922 DOI: 10.1016/j.neuint.2016.12.006  0.32
2016 Stephan G, Kowalski-Jahn M, Zens C, Schmalzing G, Illes P, Hausmann R. Inter-subunit disulfide locking of the human P2X3 receptor elucidates ectodomain movements associated with channel gating. Purinergic Signalling. 12: 221-33. PMID 26825305 DOI: 10.1007/s11302-016-9496-5  0.32
2015 Kowalski M, Hausmann R, Schmid J, Dopychai A, Stephan G, Tang Y, Schmalzing G, Illes P, Rubini P. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors. Neuropharmacology. PMID 26184350 DOI: 10.1016/j.neuropharm.2015.07.008  0.32
2015 Hausmann R, Kless A, Schmalzing G. Key sites for P2X receptor function and multimerization: overview of mutagenesis studies on a structural basis. Current Medicinal Chemistry. 22: 799-818. PMID 25439586  0.32
2014 Hausmann R, Bahrenberg G, Kuhlmann D, Schumacher M, Braam U, Bieler D, Schlusche I, Schmalzing G. A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening. Neuropharmacology. 79: 603-15. PMID 24452010 DOI: 10.1016/j.neuropharm.2014.01.010  0.32
2013 Hausmann R, Günther J, Kless A, Kuhlmann D, Kassack MU, Bahrenberg G, Markwardt F, Schmalzing G. Salt bridge switching from Arg290/Glu167 to Arg290/ATP promotes the closed-to-open transition of the P2X2 receptor. Molecular Pharmacology. 83: 73-84. PMID 23041661 DOI: 10.1124/mol.112.081489  0.32
2012 Hausmann R, Schmalzing G. P2X1 and P2X2 receptors in the central nervous system as possible drug targets. Cns & Neurological Disorders Drug Targets. 11: 675-86. PMID 22963438  0.32
2012 Hausmann R, Bodnar M, Woltersdorf R, Wang H, Fuchs M, Messemer N, Qin Y, Günther J, Riedel T, Grohmann M, Nieber K, Schmalzing G, Rubini P, Illes P. ATP binding site mutagenesis reveals different subunit stoichiometry of functional P2X2/3 and P2X2/6 receptors. The Journal of Biological Chemistry. 287: 13930-43. PMID 22378790 DOI: 10.1074/jbc.M112.345207  0.32
2011 Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor. Journal of Medicinal Chemistry. 54: 817-30. PMID 21207957 DOI: 10.1021/jm1012193  0.32
2011 Wolf C, Rosefort C, Fallah G, Kassack MU, Hamacher A, Bodnar M, Wang H, Illes P, Kless A, Bahrenberg G, Schmalzing G, Hausmann R. Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking. Molecular Pharmacology. 79: 649-61. PMID 21191044 DOI: 10.1124/mol.110.068700  0.32
2011 Bodnar M, Wang H, Riedel T, Hintze S, Kato E, Fallah G, Gröger-Arndt H, Giniatullin R, Grohmann M, Hausmann R, Schmalzing G, Illes P, Rubini P. Amino acid residues constituting the agonist binding site of the human P2X3 receptor. The Journal of Biological Chemistry. 286: 2739-49. PMID 21098022 DOI: 10.1074/jbc.M110.167437  0.32
2010 Meis S, Hamacher A, Hongwiset D, Marzian C, Wiese M, Eckstein N, Royer HD, Communi D, Boeynaems JM, Hausmann R, Schmalzing G, Kassack MU. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells. The Journal of Pharmacology and Experimental Therapeutics. 332: 238-47. PMID 19815812 DOI: 10.1124/jpet.109.157750  0.32
2007 Franklin C, Braam U, Eisele T, Schmalzing G, Hausmann R. Lack of evidence for direct phosphorylation of recombinantly expressed P2X(2) and P2X (3) receptors by protein kinase C. Purinergic Signalling. 3: 377-88. PMID 18404451 DOI: 10.1007/s11302-007-9067-x  0.32
2006 Duckwitz W, Hausmann R, Aschrafi A, Schmalzing G. P2X5 subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate. The Journal of Biological Chemistry. 281: 39561-72. PMID 17001079 DOI: 10.1074/jbc.M606113200  0.32
2006 Hausmann R, Rettinger J, Gerevich Z, Meis S, Kassack MU, Illes P, Lambrecht G, Schmalzing G. The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups. Molecular Pharmacology. 69: 2058-67. PMID 16551782 DOI: 10.1124/mol.106.022665  0.32
2005 Ullmann H, Meis S, Hongwiset D, Marzian C, Wiese M, Nickel P, Communi D, Boeynaems JM, Wolf C, Hausmann R, Schmalzing G, Kassack MU. Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. Journal of Medicinal Chemistry. 48: 7040-8. PMID 16250663 DOI: 10.1021/jm050301p  0.32
2004 Aschrafi A, Sadtler S, Niculescu C, Rettinger J, Schmalzing G. Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes. Journal of Molecular Biology. 342: 333-43. PMID 15313628 DOI: 10.1016/j.jmb.2004.06.092  0.32
2003 Failer BU, Aschrafi A, Schmalzing G, Zimmermann H. Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes. European Journal of Biochemistry. 270: 1802-9. PMID 12694193  0.32
Show low-probability matches.